Abstract Candida tropicalis has emerged as the third most prevalent fungal pathogens and its ability to form biofilms has been considered one of the most important virulence factors, since biofilms represent high tolerance to antifungal agents. However, the mechanisms of C. tropicalis biofilm resistance to antifungals remain poorly understood. Thus, the main aim of this work was to infer about the effect of voriconazole on the formation and control of C. tropicalis biofilms and disclose its relationship with ERG genes' expression. Planktonic cells tolerance of several C. tropicalis clinical isolates to voriconazole was determined through of antifungal susceptibility test, and the effect of this azole against C. tropicalis biofilm formation and pre-formed biofilms was evaluated by cultivable cells determination and total biomass quantification. ERG genes expression was analyzed by quantitative real-time polymerase chain reaction. This work showed that C. tropicalis resistance to voriconazole is strain dependent and that voriconazole was able to partially control biofilm formation, but was unable to eradicate C. tropicalis pre-formed biofilms. Moreover, C. tropicalis biofilms resistance to voriconazole seems to be associated with alterations of sterol content in the cell membrane, resulting in ERG genes overexpression. Voriconazole is unable to control C. tropicalis biofilms, and the overexpression of ERG genes is a possible mechanism of biofilm resistance.
Introduction
Invasive fungal infections, such as candidiasis, represent a public health problem of major importance, since these infections are among the leading causes of patients' morbidity and mortality [1] [2] [3] . The members of the genus Candida are the most frequently recovered from human fungal infections and are of particular importance in patients undergoing treatment for cancer, organ transplantation or receiving broadspectrum antibiotics or antifungal drugs [4] . This type of infection has emerged due to the rise of the elderly population, to a high number of immunocompromised patients and to a more widespread use of indwelling medical devices [1, [5] [6] [7] .
Candida albicans is the main cause of candidiasis and is responsible for the majority of mucosal and systemic infections [2, 4, 7] . However, in parallel with the overall increase in fungal infections, it has been observed that infections caused by non-Candida albicans Candida (NCAC) species, namely Candida tropicalis, are also emerging [2, 8, 9] . Indeed, C. tropicalis has been reported as an important causative agent of the bloodstream and urinary tract infections in hospitalized patients [2] . This increased incidence of C. tropicalis may be attributed to its biofilm formation capability [2, 9] . Biofilms are known as surfaceassociated communities of microorganisms embedded in an extracellular matrix (ECM), which may promote infection and persistence in the host [1, 7, 10, 11] . Biofilms confer significant resistance to antifungal therapy and host immune responses, by limiting the penetration of substances through the ECM [1, 4, 12] . Moreover, Candida resistance to antifungal agents has been associated with alterations of sterol content in cell membrane, which should generally cause a defective ergosterol biosynthesis, resultant from mutations in the ergosterol synthesis-associated genes (ERG genes) [13] [14] [15] .
For many decades, one of the most used antifungal agents, as a prophylactic or therapeutic response to candidiasis, was fluconazole (Flu). However, due to many Flu resistance case reported, another azole, voriconazole (Vcz), was developed in order to combat Candida infections [4] .
Many previous studies have focused on C. tropicalis tolerance to Flu, whereas there is a lack of studies concerned Vcz [11, 12, 16] . Thus, the main goal of this work was to infer about the effects of Vcz on the formation and control of C. tropicalis biofilms and disclose its relationship with ERG genes' expression.
Materials and Methods

Organisms and Growth Conditions
Three different C. tropicalis clinical isolates were used during this work: one oral strain (AG1) isolated from a patient of the Clinic Dentistry, Congregados, Braga, Portugal; one urinary tract strain (519468) recovered from a patient of the Hospital of S. Marcos, Braga, Portugal; and one vaginal strain (12) belonging to archive collection of the University of Maringá, Brazil. The strains identification of all isolates was confirmed using CHROMagar Candida medium (CHROMagar, France) and by polymerase chain reaction (PCR)-based sequencing using specific primers (ITS1 and ITS4) against the 5.8S subunit gene reference. Genomic deoxyribonucleic acid (DNA) was extracted following previously described procedures [17] . The PCR products were sequenced using the ABI-PRISM Big Dye terminator cycle sequencing kit (PerkinElmer, Applied Biosystems, Warrington, UK). For all experiments, C. tropicalis strains were subcultured on Sabouraud dextrose agar medium (SDA; Merck, Germany) for 48 h at 37°C.
Antifungal Susceptibility Tests
Minimum inhibitory concentrations (MICs) for Voriconazole (Vcz; Pfizer, New York, USA) were determined, using the microdilution method, in accordance with the guidelines of the Clinical and Laboratory Standards Institute (CLSI) [18] . Vcz was tested in concentrations of 0.5, 0.75, 1, 2, 3, 4, 6 and 10 mg/L. To confirm the MICs values, the cell suspension of each strain was recovered to a new well and serial dilutions were plated in SDA at 37°C. After 48 h of incubation, the total colony-forming units (CFUs) were determined and the results presented as Log 10 CFUs per milliliter (Log 10 CFUs/mL). Assessments of the response profiles with antifungal agent were performed in triplicate and on three different occasions.
Biofilm Formation
Biofilm formation was performed as described previously by Silva et al. [1] . An inoculum of each yeast, obtained from SDA plates, was resuspended in 30 mL of Sabouraud dextrose broth medium (SDB; Merck, Germany) and incubated for 16-18 h at 37°C, under agitation at 120 rpm. Then, cells were harvested by centrifugation at 5000g, for 10 min at 4°C and washed twice in phosphate buffer saline (PBS), pH 7.0, 0.1 M. The cell pellets were resuspended in PBS and the cellular density adjusted to 2 9 10 5 cells/mL in Roswell Park Memorial Institute 1640 medium (RPMI; Sigma, St. Louis, USA) using a Neubauer counting chamber, to be used in each experiment. The experiments were repeated in triplicate on three different occasions.
Voriconazole Effect on Biofilms
In order to study the effect of Vcz on biofilm formation, different concentrations of antifungal agent (5, 10, 50 and 100 mg/L) were prepared in RPMI 1640 medium and added at the beginning of the process of biofilm formation. The different concentrations of Vcz used were selected in accordance with MICs previously determined. For that, 100 lL of each Candida suspension containing 2 9 10 5 cells/mL and 100 lL of antifungal agent were added to the respective 96-well microplates (Orange Scientific, Braine-l' Alleud, Belgium). The microplates were incubated for 48 h at 37°C and at 120 rpm, the same period of the treatment applied during planktonic cells assays.
In order to infer about the effect of Vcz against C. tropicalis pre-formed biofilms, biofilms were previously formed during 24 h at 37°C and at 120 rpm, in RPMI 1640 medium. A volume of 100 lL of each Candida suspension was added to the respective 96-well microplates containing 100 lL of RPMI 1640 medium. After this, the medium was aspirated and different concentrations of Vcz (10, 50, 100 and 200 mg/L) prepared in RPMI 1640, were added to the specific wells to treat the pre-formed biofilms and incubated for additional 48 h at 37°C and at 120 rpm. Controls were performed with Candida cells without antifungal agent.
Biofilm Analyses
Biofilm Biomass Quantification
Biofilm total biomass was quantified by crystal violet (CV) staining [1] . For that, after biofilm formation the medium was totally aspirated and non-adherent cells were removed by washing once with 200 lL of PBS. The biofilm was fixed with 200 lL of methanol (100 % v/v), which was removed after 15 min of contact. The microplates were allowed to dry at room temperature, and 200 lL of CV (1 % v/v) was added to each well and incubated for 5 min. The wells were then gently washed twice with 200 lL of sterile ultrapure water, and 200 lL of acetic acid (33 % v/v) was added to release and dissolve the stain. The absorbance of the obtained solution was read in triplicate in a microplate reader at 570 nm. The results were presented as absorbance per unit area (Abs 570nm /cm 2 ).
Biofilm Cultivable Cells Quantification
The number of cultivable biofilm's cells was determined by the enumeration of CFUs. For this, the medium was aspirated and the biofilms washed once with 200 lL of PBS to remove non-adherent cells. Then, the biofilm was scraped from the 96-well microplates and the suspensions were vigorously vortexed for 2 min to disaggregate cells from the matrix [7] . Serial tenfold dilution in PBS was plated in SDA and incubated at 37°C for 24 h. The results were presented as the total of CFUs per unit area (log 10 CFUs/cm 2 ).
Gene Expression Analysis
Gene Selection and Primers Design for Quantitative Real-Time PCR
Five genes (ERG1, ERG3, ERG6, ERG9 and ERG11) were selected to study their expression in biofilm cells, in the presence and absence of Vcz. ACT1 gene was selected as a reference Candida housekeeping gene [19] . The gene sequences of interest were obtained from Candida Genome Database (CGD) and the primers for quantitative real-time PCR (qRT-PCR) were designed using Primer 3 (http://simgene.com/ Primer3) Web-based software (Table 1) . In order to verify the specificity of each primer pair for its corresponding target gene, PCR products were first amplified from C. tropicalis strains genomic DNA. Moreover, genomic DNA was used to infer about the primer efficiency and to determine the temperature of melting (Tm).
Biofilm Cells Preparation
Biofilms were pre-formed in 24-well microplates with a cellular density adjusted to 1 9 10 5 cells/mL in RPMI 1640 medium, using a Neubauer counting chamber. After 24 h, 1 mL of Vcz (at 100 mg/L) was added to each well and the plate incubated at 37°C for additional 48 h at 120 rpm. After this, the medium was aspirated and non-adherent cells were removed by washing twice with 1 mL of PBS, pH 7.0, 0.1 M. Then, the biofilms were scraped from the 24-well microplates, resuspended with 1 mL of PBS, and the suspensions were vigorously vortexed for 2 min to disaggregate cells from the matrix. Cells were harvested by centrifugation at 5000g for 10 min at 4°C.
RNA Extraction
Ribonucleic acid (RNA) extraction was performed using E.Z.N.A.
Ò Total RNA Kit I (Omega Bio-Tek, Norcross, USA). Prior to RNA extraction, the lysis buffer was prepared adding 1 % of b-mercaptoethanol. Then, 600 lL of lysis buffer and glass beads (425-600 lm diameter) were added to each pellet. These mixes were homogenized thrice for 30 s using a MP Biomedicals FastPrep TM -24 Instrument (Thermo Fisher Scientific, Rockford, USA). After cells disruption, the E.Z.N.A.
Ò Total RNA Kit I was used for total RNA extraction according to the manufacturer's recommended protocol. To avoid potential DNA contamination, samples were treated with RNase-free DNase I. The RNA extraction was performed in three different independents assays.
Synthesis of cDNA
To synthesize the complementary DNA (cDNA), the High Capacity cDNA Reverse Transcription Kit (Life Technologies, Carlsbad, USA) was used according to the manufacturer's instructions. For each sample, 10 lL of the extracted RNA of defined concentration was used at a final volume of 20 lL of reaction, which was completed with the remaining components of the mastermix. cDNA synthesis was performed firstly for 10 min at 25°C and then for 1 h at 37°C. The reaction was stopped by heating for 5 min at 85°C.
Quantitative Real-Time PCR
The qRT-PCR (CF X96 Real-Time PCR System; BioRad, Berkeley, USA) was used to determine the relative levels of ERG1, ERG3, ERG6, ERG9 and ERG11 messenger RNA (mRNA) transcripts in the RNA samples, using ACT1 as reference Candida housekeeping gene. Each reaction mixture consisted of a working concentration of SsoFast EvaGreen Supermix (Bio-Rad, Berkeley, USA), 10 lM forward and reverse primers, and 4 lL cDNA, in a final reaction volume of 20 lL. Negative controls (water), as well as non-transcriptase reverse (NRT) RNA controls, were included in each run. The relative quantification of genes expression was performed by the DC t method [20] , which was normalized to the housekeeping gene (C t average = 21.86 ± 0.84). Each reaction was performed in triplicate, and mean values of relative expression were determined for each gene.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism 6 software for Windows. The results were compared using a two-way ANOVA with the Bonferroni's multiple comparisons test. The variation factors assessed were always between the absence and presence of Vcz. All tests were performed with a 95 % confidence level.
Results
Candida tropicalis Voriconazole Minimum Inhibitory Concentrations
MICs of C. tropicalis were determined for Vcz using the microdilution method and CFU counts ( Table 2) . [18] and that C. tropicalis 519468 was sensible with the lowest value of MIC (0.75-1 mg/L).
Effect of the Voriconazole on Candida tropicalis Biofilms
Influence of Antifungal Agent on Biofilm Formation
In order to determine whether Vcz could prevent C. tropicalis biofilm formation, biofilms were formed during 48 h in the presence of different concentrations of antifungal agent (Fig. 1) . The data showed that all Vcz concentrations were able to cause a significant reduction in the number of cultivable cells comparatively to the control (p \ 0.0001). The same results were obtained in terms of the total biomass reduction (p \ 0.0001), however, in lower extension for the clinical isolate C. tropicalis AG1 (p \ 0.0001 only for 50 and 100 mg/L of Vcz).
Influence of Antifungal Agent on Pre-formed Biofilms
To determine the effect of Vcz on pre-formed C. tropicalis biofilms, 24-h-old biofilms were treated during 48 h with different concentrations of antifungal agent (Fig. 2) . The results revealed that Vcz was unable to reduce C. tropicalis pre-formed biofilms, either in terms of the number of cultivable cells (Fig. 2a) and total biomass (Fig. 2b ). Moreover, it was possible to observe for C. tropicalis 12 biofilms a significant increase in terms of total biomass at all Vcz concentrations (p \ 0.0001 at concentrations of 10, 50 and 100 mg/L and p \ 0.05 at concentrations of 200 mg/L). The total biomass also increased for C. tropicalis 519468, however, only for the lowest concentration of Vcz tested (10 mg/L) (p \ 0.01) (Fig. 2b) . Figure 3 presents the mean n-fold expression levels of ERG1, ERG3, ERG6, ERG9 and ERG11 genes of the C. tropicalis cells (from pre-formed biofilms) treated with Vcz (100 mg/L), in comparison with the control (absence of antifungal agent). This concentration of Statistically different compared to respective control. **, *** and ****correspond to p \ 0.01, p \ 0.001 and p \ 0.0001, respectively Vcz was selected once the main aim was to disclose the effect of the ERG genes on C. tropicalis biofilms resistance to azole.
Effect of the Voriconazole on ERG Genes Expression
An overexpression of all ERG genes was evident for all C. tropicalis biofilm cells treated with Vcz (Fig. 3) , although differences were observed depending on the strains and the ERG gene. ERG6 presented the highest levels of expression for all strains (Fig. 3c) , and ERG1 (Fig. 3a) and ERG9 (Fig. 3d ) the lower levels for biofilm cells treated with Vcz. It should be noted that, in the presence of Vcz (Fig. 3) , C. tropicalis AG1 biofilm cells showed the highest expression for all ERG genes with less significant differences for the other two strains.
Discussion
The main aim of this study was to determine the effect of the Vcz on C. tropicalis biofilms and to disclose its relationship with the ERG genes expression, and thus deepen the knowledge regarding C. tropicalis biofilms resistance mechanisms.
To reach the goal of this study, antifungal susceptibility tests were performed according to CLSI guidelines. Although the agent tested belong to the azoles' class, Vcz was selected due to its more recent use, which is related to a better efficacy in the combat of candidiasis and consequent lower resistance than other azoles [4] . So, as expected, not all clinical isolates were resistant to Vcz with MIC values strain dependent (Table 2 ). These differences highlight the strain susceptibility variations resultant from the different origins of the clinical isolates, which were recovered from patients submitted to different therapies [4, 8, 21, 22] .
As it is known, biofilms have been considered the most prevalent growth form of microorganisms in natural environments [4, 23, 24] . Biofilms present a high versatility in adapting to a variety of different habitats, being described as surface-associated communities of microorganisms embedded within an extracellular matrix [1, 4, 7, 10] . All C. tropicalis clinical isolates assayed were able to form biofilms with higher resistant to Vcz than their planktonic cells, which is in agreement with other studies [4, 22, 25] . Additionally, this work revealed that Vcz possessed a significant effect on C. tropicalis biofilms' formation, as evidenced by the significant reductions in the number of cultivable cells and in total biomass values ( Fig. 1) , but without effect on pre-formed biofilms (Fig. 2) . On the other hand, even the highest concentration of Vcz was unable to reduce/destroy C. tropicalis pre-formed biofilms (Fig. 2) . It should also be emphasized that even the lowest concentration tested of Vcz (5 mg/L) was able to reduce the biofilm (Fig. 1) , what is a very important issue regarding cytotoxicity and therefore patient's safety. As is now, pre-formed biofilms are mature biofilms, which subsequently possesses a complex extracellular matrix, that difficult the penetration of agents, presenting higher resistance to antifungals [4, 23, 26, 27] . Interestingly, it was observed an increase in total biomass when pre-formed biofilms were treated with intermediate concentrations of antifungal agent (Fig. 2b) . This phenomenon is probably due to a response of C. tropicalis biofilm cells to the stress caused by the presence of the agent, which lead to an expansion of the biofilm matrices' production.
It is known that the antifungal agents from the azole class, with fungistatic activity, inhibit the biosynthesis of ergosterol by interfering with the fungal enzyme, lanosterol demethylase, which is a key enzyme in the biosynthesis of ergosterol [4, 23] . Several molecular mechanisms of azole antifungals' resistance have been reported for other Candida species, including alteration in the chemical structure of the demethylase enzyme, removal of the azole from the cell by multidrug transporter pumps and compensation by other sterol synthesis enzymes in membrane biosynthesis [23] . Despite some information related to other Candida species [13, 22, 23, 28] , there is a lack of information concerning the involvement of wellknown mechanisms of Vcz resistance in C. tropicalis. Thus, to disclose the effective role of expression of ERG genes (ERG1, ERG3, ERG6, ERG9 and ERG11) on biofilms' resistance, their expression was measured in C. tropicalis biofilm cells treated with of Vcz, by qRT-PCR. This work was demonstrative that the expression of all ERG genes increased for biofilm cells treated with Vcz (Fig. 3) . Thus, it can be concluded that the resistance of C. tropicalis biofilm cells to azole appears to be related to overexpression in ERG11 gene, possibly due to qualitative modifications in enzyme lanosterol 14a-demethylase that convert lanosterol to ergosterol, leading to depletion of the sterol of cell membrane due to the inhibition of the biosynthesis of ergosterol. Moreover, ERG6 gene was also over expressed in the presence of Vcz (Fig. 3c ). ERG6 gene is described as required for a normal b Fig. 3 Effect of voriconazole on values of n-fold expression levels of ERG1 (a), ERG3 (b), ERG6 (c), ERG9 (d) and ERG11 (e) genes in pre-formed Candida tropicalis biofilms. Biofilms were formed during 24 h and treated with 100 mg/L of voriconazole during 48 h. Comparisons were made with biofilm cells growth in the absence of antifungal. Error bars indicate the SDs. *, **, *** and **** correspond to p \ 0.05, p \ 0.01, p \ 0.001 and p \ 0.0001, respectively membrane function and is localized after the ERG11 gene in ergosterol biosynthesis cascade. Thus, it can be speculated that after qualitative modifications in enzyme lanosterol 14a-demethylase, caused by Vcz due to the overexpression in ERG11 gene, it could be reflected in an overexpression of ERG6 gene and thus can affect the normal membrane function [4] . In contrast, the genes with lowest expression levels were the ERG1 (Fig. 3a) and the ERG9 (Fig. 3d) . It should be pointed out that ERG9 and ERG1 appear before the ERG11 gene in ergosterol biosynthesis, thus seeming to be possible that its response assumes less importance than from the other genes, in C. tropicalis biofilm cells resistance to Vcz. Mature C. tropicalis biofilms are constitutes by several layers of cells that make impossible the antifungal agents reach all cells and this may be an explanation for the absence statically differences between C. tropicalis 12 and 519468 levels of ERG genes expression.
Conclusions
In conclusion, this study confirmed that the pattern of resistance of C. tropicalis planktonic cells to Vcz is strain dependent. Moreover, it was also demonstrated that Vcz was able to control partly C. tropicalis biofilm formation but unable of eradicating C. tropicalis pre-formed biofilms. In addition, this work revealed for the first instance that ERG genes could be implicated in the mechanisms of C. tropicalis biofilm's cells resistance to Vcz.
